RENAL CARCINOMA
Clinical trials for RENAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL CARCINOMA trials appear
Sign up with your email to follow new studies for RENAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink kidney tumors before surgery
Disease control Recruiting nowThis study tests whether the drug casdatifan, alone or with zimberelimab, can safely shrink kidney tumors before surgery. It involves 32 adults with clear cell renal cell carcinoma who are scheduled for kidney removal. The goal is to see if these drugs reduce tumor size and are s…
Matched conditions: RENAL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Targeted drug shows promise for Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests a daily pill called olaparib in people with advanced kidney cancer that has certain gene mutations (like BAP-1 or BRCA). The goal is to see if the drug can shrink tumors or keep them stable for at least six months. About 20 adults who have already tried other tre…
Matched conditions: RENAL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Cheaper pain cocktail may beat exparel after kidney surgery
Symptom relief Recruiting nowThis study compares two pain relief methods used during robotic kidney surgery: a cheaper mix of drugs called R.E.C.K and a more expensive option called Exparel. About 170 adults having robotic kidney removal will be randomly assigned to one of the two treatments. Researchers wil…
Matched conditions: RENAL CARCINOMA
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 17, 2026 02:06 UTC